Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology

Affiliations

¹ Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
² Institute for Medical Genetics and Applied Genomics, Center for Rare Diseases, University of Tübingen, Tübingen, Germany.
³ Department of Neurology, University Medical Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
⁴ Urgent Neurology, Faculty of Medicine, University Clinic of Neurology, University Ss. Cyril and Methodius, Skopje, North Macedonia.
⁵ Department of Clinical and Movement Neurosciences, University College London, Institute of Neurology, Queen Square, London, UK.

Editorial

Michelangelo Mancuso et al. Eur J Neurol. 2023 Jun.

. 2023 Jun;30(6):1553-1554.

doi: 10.1111/ene.15752. Epub 2023 Mar 12.

¹ Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
² Institute for Medical Genetics and Applied Genomics, Center for Rare Diseases, University of Tübingen, Tübingen, Germany.
³ Department of Neurology, University Medical Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.
⁴ Urgent Neurology, Faculty of Medicine, University Clinic of Neurology, University Ss. Cyril and Methodius, Skopje, North Macedonia.
⁵ Department of Clinical and Movement Neurosciences, University College London, Institute of Neurology, Queen Square, London, UK.

No abstract available

Keywords: awareness; neurogenetics; rare diseases; rare neurological diseases.

References

1. Mancuso M, Houlden H, Molnar MJ, et al. How to approach a neurogenetics diagnosis in different European countries: the European Academy of Neurology Neurogenetics Panel survey. Eur J Neurol. 2022;29:1885-1891.